CLOV icon

Clover Health Investments

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 73.1%
Negative

Neutral
GlobeNewsWire
11 days ago
Clover Health to Participate in Upcoming 2025 Citi Global Healthcare Conference
WILMINGTON, Del., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial Officer, Peter Kuipers, will present at the 2025 Citi Global Healthcare Conference on Thursday, December 4, 2025, at 11:15 a.m. Eastern Time.
Clover Health to Participate in Upcoming 2025 Citi Global Healthcare Conference
Neutral
Seeking Alpha
17 days ago
Clover Health Investments, Corp. (CLOV) Presents at UBS Global Healthcare Conference 2025 Transcript
Clover Health Investments, Corp. ( CLOV ) UBS Global Healthcare Conference 2025 November 11, 2025 11:00 AM EST Company Participants Peter Kuipers - Chief Financial Officer Presentation Unknown Analyst Okay. All right.
Clover Health Investments, Corp. (CLOV) Presents at UBS Global Healthcare Conference 2025 Transcript
Positive
Zacks Investment Research
22 days ago
Why Fast-paced Mover Clover Health Investments (CLOV) Is a Great Choice for Value Investors
Clover Health Investments (CLOV) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Why Fast-paced Mover Clover Health Investments (CLOV) Is a Great Choice for Value Investors
Neutral
Zacks Investment Research
23 days ago
CLOV Q3 Earnings Miss, Stock Falls on Raised Insurance BER View
Clover Health's Q3 sales soar 50%, but higher Insurance costs and a raised BER outlook weigh on investor sentiment.
CLOV Q3 Earnings Miss, Stock Falls on Raised Insurance BER View
Neutral
Seeking Alpha
24 days ago
Clover Health Investments, Corp. (CLOV) Q3 2025 Earnings Call Transcript
Clover Health Investments, Corp. ( CLOV ) Q3 2025 Earnings Call November 4, 2025 5:00 PM EST Company Participants Ryan Schmidt - Investor Relations Analyst Andrew Toy - Co-Founder, CEO & Director Peter Kuipers - Chief Financial Officer Conference Call Participants Jonathan Yong Presentation Operator Hello, and welcome to Clover Health's Third Quarter 2025 Earnings Call. [Operator Instructions] Also, as a reminder, this conference is being recorded today.
Clover Health Investments, Corp. (CLOV) Q3 2025 Earnings Call Transcript
Neutral
Zacks Investment Research
24 days ago
Clover Health Investments, Corp. (CLOV) Reports Break-Even Earnings for Q3
Clover Health Investments, Corp. (CLOV) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of $0.02. This compares to a loss of $0.02 per share a year ago.
Clover Health Investments, Corp. (CLOV) Reports Break-Even Earnings for Q3
Positive
24/7 Wall Street
24 days ago
Clover Health Surges: Profit, Revenue, Membership Up
Clover Health Investments (NASDAQ: CLOV) delivered its second consecutive profitable quarter tonight, beating earnings expectations and extending a streak of operational improvement that has quietly reshaped the Medicare Advantage insurer's narrative.
Clover Health Surges: Profit, Revenue, Membership Up
Neutral
GlobeNewsWire
24 days ago
Clover Health Reports Third Quarter 2025 Results
Business Highlights: Generates third quarter year-to-date positive Adjusted EBITDA profitability, on a wide network, while growing membership by 35% and revenue by 39% year-over-year, despite a greater proportion of new members relative to returning member base High coverage of Clover Assistant, including within new cohorts, will result in improved total cost of care Strong retention, above-market growth, and profitable returning member cohorts position Clover for improved positive FY26 Financial Results Financial Results: Third quarter 2025 Medicare Advantage membership of 109,226, up 35% year-over-year Third quarter 2025 Total revenues of $497 million, up 50% year-over-year Third quarter 2025 profitability metrics include GAAP Net loss of $24 million, Adjusted EBITDA of $2 million, and Adjusted Net income of $2 million Third quarter year-to-date GAAP Net loss of $36 million , Adjusted EBITDA of $45 million , and Adjusted Net Income of $44 million Revised Full Year 2025 Guidance: Increases Average Medicare Advantage membership to 106,000 - 108,000, representing 33% growth year-over-year at the midpoint Increases Insurance revenue to between $1.850 billion and $1.880 billion, representing 39% growth year-over-year at the midpoint Improves Adjusted SG&A to between $325 million and $335 million, representing Adjusted SG&A as a percentage of Total revenues between 17% - 18% Expects Adjusted EBITDA profitability between $15 million and $30 million Expects Adjusted Net income between $15 million and $30 million Expects Insurance BER between 90% - 91% Directional Full Year 2026 Outlook: Company intends to maintain strong, sustainable growth, similar to 2025 Strong start to AEP with high applications in core markets. High expected retention Expect strong returning member cohort economics, 4.0 Star payment year, favorable CMS rate update, Increased Part D direct subsidy will enable increasing Adjusted EBITDA profitability WILMINGTON, Del.
Clover Health Reports Third Quarter 2025 Results
Neutral
GlobeNewsWire
28 days ago
Clover Health Announces Chelsea Clinton to Step Down from Board Following Eight Years of Service
WILMINGTON, Del., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) today announced that Chelsea Clinton, the longest-serving member of its Board of Directors, having joined the Board in early 2017, will conclude her service as of October 31, 2025.
Clover Health Announces Chelsea Clinton to Step Down from Board Following Eight Years of Service
Neutral
GlobeNewsWire
29 days ago
Primary Care Physician Use of Counterpart Assistant (CA) Technology Associated With Earlier Diagnosis And Less Frequent Hospitalization In Underserved Populations
New whitepaper demonstrates how CA enables primary care teams in resource-constrained settings to prevent, detect, and manage chronic disease. New whitepaper demonstrates how CA enables primary care teams in resource-constrained settings to prevent, detect, and manage chronic disease.
Primary Care Physician Use of Counterpart Assistant (CA) Technology Associated With Earlier Diagnosis And Less Frequent Hospitalization In Underserved Populations